ArticleJournal of neuro-oncology2025
Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimTo investigate how collagen type I alpha 1 gene (COL1A1) affects hypoxic glioblastoma (GBM) cell radiosensitivity and explore underlying mechanisms. MAIN
methodsWe used GBM patients' bulk and single cell RNA sequencing (RNA-seq and scRNA-seq) data along with clinical data from various public databases to assess COL1A1 expression and its cell subgroups, with the Kaplan-Meier method for survival analysis. We used bioinformatics to identify correlations between COL1A1 and hypoxia-related pathways and fluorescence-based real-time quantitative polymerase chain reaction and immunoblotting to detect COL1A1 expression changes in GBM cells. Stable GBM cells with COL1A1 overexpression or knockdown were established using lentiviral vectors. We used CCK-8 assay, flow cytometry, and plate colony formation assay to evaluate GBM cells' proliferation, apoptosis, and radiosensitivity, respectively. We assessed autophagic flux with mRFP-GFP-LC3 dual fluorescence labeling and evaluated expression of apoptosis-related proteins (PARP, LC3B, P62) and DNA repair protein γ-H2Ax through immunoblotting. KEY
findingsIn GBM patients, COL1A1 demonstrated universally strong expression which was significantly associated with shortened survival. In scRNA-seq data, COL1A1 is associated with a distinct cell subgroup whose functions are enriched in epithelial-mesenchymal transition (EMT), angiogenesis, protein secretion, and DNA repair. In GBM cells, irradiation and hypoxia increased COL1A1 expression; under hypoxic conditions, COL1A1 overexpression promoted proliferation. However, in hypoxic M059K cells, COL1A1 knockdown strongly inhibited growth and autophagy but increased radiosensitivity and apoptosis. Conversely, COL1A1 overexpression increased radioresistance and autophagy but inhibited apoptosis in hypoxic U251MG cells.Blocking the autophagy pathway weakened the regulation of radiosensitivity by COL1A1 in hypoxic GBM cells.
Indexed as
Identifiers
40794247What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.